Absorbable Poloxamer-Dextran Bone Hemostatic Composition

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current surgical methods for controlling osseous hemorrhage and promoting bone healing are inadequate, as existing bone hemostatic agents are non-absorbable, ineffective in adhering to bone, and do not reliably promote osteogenesis, while available bone healing materials lack cohesive properties and biocompatibility.

Innovation Solution

A composition comprising solid poloxamer, high molecular weight dextran, and optionally a fatty acid salt, providing a putty-like consistency that adheres to bone and functions as both a mechanical hemostatic agent and an osteogenic promoter, capable of being absorbed by the body.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If non-absorbable bone wax is used for hemostasis, then bleeding control is effective, but osteogenesis is inhibited and infection risk increases

Engineering Contradiction:
Improvehemostasis effectivenessVSAvoidinfection risk and osteogenesis inhibition
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent changes the fundamental parameter of absorbability from non-absorbable (traditional bone wax) to absorbable (poloxamer-dextran composition). This allows the material to perform hemostasis temporarily then be naturally resorbed, eliminating the permanent foreign body that causes infection and osteogenesis inhibition. The composition maintains hemostatic effectiveness during the needed period while avoiding long-term harmful effects.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent uses a composite material system combining poloxamer (for hemostasis and adhesion) with dextran (for absorbability and biocompatibility). This composite approach allows the material to simultaneously achieve effective hemostasis, bone adhesion, and natural resorption, resolving the contradiction between hemostatic reliability and harm reduction.

Inventive Principle:
Principle #40Composite materials

2Object-generated harmful factors

If paste-like bone healing materials are used to fill defects, then osteogenesis is promoted, but adhesion to bone is unreliable and hemostasis is ineffective

Engineering Contradiction:
Improveosteogenesis promotionVSAvoidadhesion and hemostasis effectiveness
Core Design Contradiction:
Object-generated harmful factorsVSReliability

Solution Approach 1:

The patent creates a multi-functional material that simultaneously performs hemostasis, adhesion to bone, and promotion of osteogenesis. The poloxamer component provides adhesion and hemostasis, while the dextran component supports osteogenesis and ensures absorbability. This universal material eliminates the need for separate hemostatic and osteogenic materials.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The patent changes the physical state parameter from loose paste to cohesive putty-like consistency. This physical transformation allows the material to adhere reliably to bone surfaces while maintaining the ability to promote osteogenesis and provide effective hemostasis, resolving the reliability issues of paste-like materials.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If electrocautery is used for hemostasis, then bleeding is controlled, but tissue damage occurs and osteogenesis is delayed

Engineering Contradiction:
Improvehemostasis effectivenessVSAvoidtissue damage and osteogenesis delay
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent replaces the thermal/mechanical action of electrocautery with a chemical/biological hemostatic mechanism. The poloxamer-dextran composition achieves hemostasis through adhesion to exposed bone and promotion of coagulation, avoiding the thermal damage and tissue necrosis caused by electrocautery, thereby preventing osteogenesis delay.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The composition effectively controls bleeding, promotes bone growth, and is absorbable, reducing the risk of infection and enhancing bone healing without causing tissue damage or delaying osteogenesis.

Implementation Method 1

providing a putty-like consistency that adheres to bone

Methodology Applied
Scientific EffectAdhesion: Adhesive

Implementation Method 2

capable of being absorbed by the body

Methodology Applied
Scientific EffectAbsorption: Absorption (physical)

Data Source

PatentUS10342892B2Absorbable compositions and methods for their use in hemostasis
Publication Date: 2019.07.09 XTANT MEDICAL HOLDINGS INC

AI summary

The present invention is direct to a body-absorbable, mechanically hemostatic composition comprising a solid poloxamer having an average molecular weight of about 7,000 g/mol to about 15,000 g/mol, a high molecular weight dextran, optionally a fatty acid salt, and water, and a method for mechanically controlling the bleeding of bone comprising applying an effective amount of the composition to the affected area.